Goldman Sachs Exchanges artwork

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

Goldman Sachs Exchanges

English - November 07, 2023 05:00 - 26 minutes - ★★★★ - 769 ratings
Business Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Impactive Capital’s private equity approach to ESG-oriented activism
Next Episode: BlackRock’s Tony Kim on the ‘dawn of a new intelligence era’

Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.